A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure
Clinical trial NCT04714320 · COMPLETED
Trial details
- NCT number
- NCT04714320
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2022-06-29
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.